Contact Your Lawmakers

Contact your Representative about H.R. 3
The U.S. House of Representatives recently passed H.R. 3, a drug pricing package which includes significant changes to Medicare and the drug reimbursement system across the United States. The bill could reduce biopharmaceutical industry revenues by $1 trillion over the next decade and put nearly 1 million U.S. jobs at risk.  H.R. 3 could also lead to 100 fewer drugs entering the U.S. market, denying patients access to lifesaving cures.  We urge you to take action and thank your representative if he/she voted against H.R. 3 or express disappointment if he/she voted “yes” on this proposal.

Urge Congress to Oppose the Proposed International Pricing Index Model
The Administration recently proposed the International Pricing Index (IPI) Model, which would base prices for medicines in Medicare Part B on prices mandated by foreign governments. Tell your Members of Congress to oppose the proposed IPI model.